Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
N.MMED.WR
Primary Symbol:
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED.WA
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(10)
•••
Superss63
X
View Profile
View Bullboard History
Post by
Superss63
on May 20, 2021 3:59pm
Squeeze
Might see a squeeze here.
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on May 20, 2021 8:39am
MindMed’s Mescaline Study Approved For Clinical Trial
MindMed announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have been approved by the local Swiss ethics committee. The trial is set to
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(220)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on May 19, 2021 10:44pm
MMED SHORT INTEREST... Pay us B*tches. See below
(220)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on May 19, 2021 10:27pm
Short squeeze, incoming.........
EOM
(25)
•••
supergarvis
X
View Profile
View Bullboard History
Post by
supergarvis
on May 19, 2021 6:14am
The Chopra Foundation and MindMed Enter Into Letter of Inten
https://thecannabisstock.com/2021/05/18/the-chopra-foundation-and-mindmed-enter-into-letter-of-intent-to-partner-on-the-future-of-psychedelic-medicines-mental-wellbeing/
(220)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on May 18, 2021 9:08pm
Deepak Chopra and MMED unite! This IS big news. Love it.....
The Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental Wellbeing PR Newswire NEW YORK , May 18, 2021
...more
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on May 18, 2021 4:11pm
Tomorrow is another day
Stay tuned
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on May 18, 2021 2:02pm
Next stop $4.30...Some of you will feel a slight pinch
:)
(45)
•••
Idvhmz123
X
View Profile
View Bullboard History
Post by
Idvhmz123
on May 17, 2021 9:48am
Psychedelic News
ORIGINAL: HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches 2021-05-17 08:01 ET - News Release HAVN Life works towards
...more
(36)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on May 15, 2021 11:05am
Great YT analysis on MNMD
https://youtu.be/NYyTeQICTIo
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on May 14, 2021 8:05am
Going up folks :)
Get your ticket NOW
(16)
•••
TeddyTenBags
X
View Profile
View Bullboard History
Comment by
TeddyTenBags
on May 13, 2021 11:53pm
RE:RE:RE:Curious on valuation
TRIP is a joke. Run by a guy who used to be a complete idiot on a morning radio show in Toronto with Russell Peters as Chief Creative Officer. They are purely a recreational play, which is a longgggg
...more
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Post by
TheTerminator1
on May 13, 2021 6:47pm
MDMA-Assisted Therapy for PTSD: What to know
https://www.webmd.com/mental-health/what-is-mdma-assisted-therapy-ptsd
(19)
•••
skelterhelter
X
View Profile
View Bullboard History
Comment by
skelterhelter
on May 13, 2021 3:48pm
RE:RE:Curious on valuation
thank you
(42)
•••
RiskyBiz928
X
View Profile
View Bullboard History
Comment by
RiskyBiz928
on May 13, 2021 12:29pm
RE:Curious on valuation
Skelter: Try TRIP - also in the shroom space. Cheaper entry, same risk. Market is speculative, boom or bust.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >